Myrbetriq is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Mirabegron.
| Product ID | 55154-8712_1b9ded22-d5c2-4380-8de6-1ff4a48da75f | 
| NDC | 55154-8712 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Myrbetriq | 
| Generic Name | Mirabegron | 
| Dosage Form | Tablet, Film Coated, Extended Release | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2012-06-28 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA202611 | 
| Labeler Name | Cardinal Health | 
| Substance Name | MIRABEGRON | 
| Active Ingredient Strength | 25 mg/1 | 
| Pharm Classes | beta3-Adrenergic Agonist [EPC],Adrenergic beta3-Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2012-06-28 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA202611 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2012-06-28 | 
| Ingredient | Strength | 
|---|---|
| MIRABEGRON | 25 mg/1 | 
| SPL SET ID: | aaaf3bea-1b21-4edf-9300-b7159ea9ede8 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0469-2601 | Myrbetriq | mirabegron | 
| 0469-2602 | Myrbetriq | mirabegron | 
| 0469-5020 | Myrbetriq | mirabegron | 
| 55154-8712 | Myrbetriq | mirabegron | 
| 55154-8713 | Myrbetriq | mirabegron | 
| 70518-2435 | Myrbetriq | mirabegron | 
| 70518-3158 | Myrbetriq | mirabegron | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  MYRBETRIQ  85595770  4263728 Live/Registered | Astellas Pharma Inc. 2012-04-12 |